78 samples
Export
<<< of 4>>>
Accession Title Sample type Organism(s) Ch Platform Series Supplementary Contact Release date
Remove filtersFilter Remove filterGSE200486
GSM6034915
Feces of a patient affected by limited (ACA) sclerodermia [F_01_L]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034916
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_02_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034917
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_03_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034918
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_04_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034919
Feces of a patient affected by limited (ACA) sclerodermia [F_05_L]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034920
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_06_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034921
Feces of a patient affected by limited (ACA) sclerodermia [F_07_L]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034922
Feces of a patient affected by limited (ACA) sclerodermia [F_08_L]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034923
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_09_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034924
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_10_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034925
Feces of a patient affected by limited (ACA) sclerodermia [F_11_L]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034926
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_12_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034927
Feces of a patient affected by limited (ACA) sclerodermia [F_13_L]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034928
Feces of a patient affected by limited (ACA) sclerodermia [F_14_L]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034929
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_15_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034930
Feces of a patient affected by limited (ACA) sclerodermia [F_16_L]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034931
Feces of a patient affected by limited (ACA) sclerodermia [F_17_L]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034932
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_18_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034933
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_19_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023
GSM6034934
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_20_D]
SRA 1
  • Link icon GSE200486
Matteo Ramazzotti Dec 28, 2023